Your broker says “the banks are flying”, but your CPF and SRS need more than a happy headline, they need hard numbers on what you’re actually being paid for every new dollar you put into DBS, OCBC and UOB. In this episode, I walk through why DBS just moved from a borderline income workhorse to Zone 4 Caution at S$69.74, even though the business itself is still rock solid. We’ll separate OCBC’s fortress balance sheet from its much weaker yield story, and keep UOB in its proper Zone 2 Preliminary bucket ahead of the August 7 earnings date. By the end, you’ll know exactly which “record high” is a safe sleep-at-night name, and which one is now a wait-for-better-price candidate for your retirement pot.
Key takeaways:
DBS total yield now around 4.39% at S$69.74, below a 4.7% income hurdle.
OCBC’s 17.0% CET1 and 0.9% NPL make it the safest balance sheet, not the strongest paycheque.
UOB’s already-thin yield is slipping further as price runs ahead of its August 7 review.
“The banks” is three separate verdicts: DBS Zone 4 Caution, OCBC Zone 1 Fortress, UOB Zone 2 Preliminary.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
